259 related articles for article (PubMed ID: 19288586)
1. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
[TBL] [Abstract][Full Text] [Related]
2. Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics.
Ibáñez C; Simó C; Martín-Álvarez PJ; Kivipelto M; Winblad B; Cedazo-Mínguez A; Cifuentes A
Anal Chem; 2012 Oct; 84(20):8532-40. PubMed ID: 22967182
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry.
Li NJ; Liu WT; Li W; Li SQ; Chen XH; Bi KS; He P
Clin Biochem; 2010 Aug; 43(12):992-7. PubMed ID: 20457143
[TBL] [Abstract][Full Text] [Related]
4. A new metabolomic workflow for early detection of Alzheimer's disease.
Ibáñez C; Simó C; Barupal DK; Fiehn O; Kivipelto M; Cedazo-Mínguez A; Cifuentes A
J Chromatogr A; 2013 Aug; 1302():65-71. PubMed ID: 23827464
[TBL] [Abstract][Full Text] [Related]
5. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
7. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
8. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.
Wang DC; Sun CH; Liu LY; Sun XH; Jin XW; Song WL; Liu XQ; Wan XL
Neurobiol Aging; 2012 Jun; 33(6):1057-66. PubMed ID: 20980076
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarkers for Alzheimer's disease: proteomic discovery.
German DC; Gurnani P; Nandi A; Garner HR; Fisher W; Diaz-Arrastia R; O'Suilleabhain P; Rosenblatt KP
Biomed Pharmacother; 2007 Aug; 61(7):383-9. PubMed ID: 17614251
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
Zhang HY; Chen X; Hu P; Liang QL; Liang XP; Wang YM; Luo GA
Talanta; 2009 Jul; 79(2):254-9. PubMed ID: 19559874
[TBL] [Abstract][Full Text] [Related]
11. Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry.
Cai X; Zou L; Dong J; Zhao L; Wang Y; Xu Q; Xue X; Zhang X; Liang X
Anal Chim Acta; 2009 Sep; 650(1):10-5. PubMed ID: 19720166
[TBL] [Abstract][Full Text] [Related]
12. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
Liu Y; Li N; Zhou L; Li Q; Li W
Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
[TBL] [Abstract][Full Text] [Related]
13. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.
Bijlsma S; Bobeldijk I; Verheij ER; Ramaker R; Kochhar S; Macdonald IA; van Ommen B; Smilde AK
Anal Chem; 2006 Jan; 78(2):567-74. PubMed ID: 16408941
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
Song F; Poljak A; Smythe GA; Sachdev P
Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender.
Lutz U; Lutz RW; Lutz WK
Anal Chem; 2006 Jul; 78(13):4564-71. PubMed ID: 16808466
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
17. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
19. Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.
Hu ZP; Browne ER; Liu T; Angel TE; Ho PC; Chan EC
J Proteome Res; 2012 Dec; 11(12):5903-13. PubMed ID: 23078235
[TBL] [Abstract][Full Text] [Related]
20. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
